Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Igm Biosciences Inc (NQ: IGMS ) 9.270 +0.550 (+6.31%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Igm Biosciences Inc < Previous 1 2 Next > IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update August 14, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Jefferies Healthcare Conference May 29, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update May 08, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference May 07, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Refocusing of Sanofi Collaboration April 17, 2024 Agreement focuses on immunology/inflammation, aligning with Sanofi’s ongoing commitment to advancing therapies for patients across multiple inflammatory diseases From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum April 10, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 07, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference February 01, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension December 05, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Third Quarter 2023 Financial Results November 13, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at Two Upcoming Investor Conferences November 07, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors October 03, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference September 06, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Second Quarter 2023 Financial Results August 03, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares July 03, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement June 22, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Announces Proposed Public Offering and Concurrent Private Placement June 21, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development June 02, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Jefferies Healthcare Conference June 01, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis May 31, 2023 Imvotamab, a CD20 x CD3 bispecific monoclonal antibody, offers potential for deeper B cell depletion than currently approved therapies From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update May 30, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update May 12, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at Two Upcoming Investor Conferences May 02, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days April 19, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023 April 13, 2023 Presentations highlight data from across all oncology pipeline programs From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update March 30, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 March 27, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference February 02, 2023 From IGM Biosciences, Inc. Via GlobeNewswire IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors January 17, 2023 – Targeted IL-15/IL-15R IgM antibody to be evaluated for safety and pharmacodynamic effects – From IGM Biosciences, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.